Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma-Reference-Cited by-同舟云学术

Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma

Published:2018-10-23 Issue:2 Volume:25 Page:868-880
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Poty Sophie^ORCID,Carter Lukas M.^ORCID,Mandleywala Komal,Membreno Rosemery,Abdel-Atti Dalya,Ragupathi Ashwin,Scholz Wolfgang W.,Zeglis Brian M.,Lewis Jason S.^ORCID

Funder

HHS | National Institutes of Health (NIH)

Mr. William H. and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research

Center for experimental therapeutics of Memorial Sloan Kettering Cancer Center

JLM Benevolent Fund

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing the Therapeutic Index of sdAb-Based Radiopharmaceuticals Using Pretargeting;Journal of Nuclear Medicine;2024-09-12

2. Ways to reduce radioactivity accumulation in the kidney during targeted therapy using small molecules, peptides and antibody fragments;Siberian journal of oncology;2024-09-09

3. BNCT pancreatic cancer treatment strategy with glucose-conjugated boron drug;Biomaterials;2024-09

4. A Technique to Quantify Very Low Activities in Regions of Interest With a Collimatorless Detector;IEEE Transactions on Medical Imaging;2024-08

5. Examination of the PET in vivo generator 134Ce as a theranostic match for 225Ac;European Journal of Nuclear Medicine and Molecular Imaging;2024-06-28